1747, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From 1747, Inc.
Corporate Venture Capital's Complex Agenda
Several forces--rapid technological obsolescence, the impact of information technology on health care, merger integrations, and the need for double digit revenue growth--have caused increasing numbers of large pharmaceutical and medical device companies to create new corporate venture capital groups. But compared to traditional VC firms, whose only goal is to make money for limited partners, corporate VCs have a heavy agenda. They must choose portfolio companies while balancing often-competing goals of strategic benefit and financial return.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
- Digital Health
- Other Names / Subsidiaries
-
- 1747 Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice